top of page
1-844-KRTL-BIO
Schedule a Consultation
A Wholly Owned Subsidiary of KRTL Holding Group Inc (OTC: KRTL)
Home
About
Services
Clinical & Post Market Support
Quality Control & Quality Assurance
Product Labeling & Compliance
Supply Chain & Logistics
Manufacturing Services
U.S. Agent Representation
Import & Export Logistics
Regulatory Registration & Compliance
News
Knowledge Center
Log In
KRTL NEWS
KRTL Holding Appoints Dave Orn and Rick Haxton to Accelerate Global Growth at KRTL Biotech Inc.
KRTL Holding
Jun 5
KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative
KRTL Holding
Jun 4
KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
KRTL Holding
Apr 9
KRTL Holding Group, Inc Commences Trading on Upstream Under KRTL
KRTL Holding
Apr 2
KRTL Holding Group, Inc Approved to Dual List on Upstream
KRTL Holding
Mar 25
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria QuÃmico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
KRTL Biotech
Mar 24
KRTL Biotech Implements MasterControl QMS to Enhance Regulatory Compliance and Pharmaceutical Importation Readiness
KRTL Biotech
Mar 3
KRTL Holding Group Inc. Appoints Philip Polito to Board of Directors as Chief Strategy Officer
KRTL Biotech
Feb 12
KRTL Holding Group Inc. Appoints Marlen Patricia Wilstermann-Sanzetenea as International Pharmaceutical Sales Director
KRTL Biotech
Feb 12
KRTL Holding Group Inc. Welcomes Dr. Marcelo Bascope as Chief International Science Director
KRTL Biotech
Feb 12
KRTL Holding Group Expands in Bolivia: A Strategic Leap for Biopharmaceutical Innovation
KRTL Biotech
Feb 5
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria QuÃmico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
KRTL Biotech
Jan 22
KRTL Holding Group Inc. Announces FDA FEI and NDC Certification Achievements by Wholly Owned Subsidiary KRTL Biotech Inc.
KRTL Biotech
Jan 15
KRTL Holding Group Inc. Announces KRTL Biotech Inc. Acquires 55% Majority Stake in Nutrivance Global to Enhance API Distribution and Real-World Data Capabilities
KRTL Biotech
Jan 8
KRTL Holding Group Inc. (OTC: KRTL) Announces Launch of New KRTL Biotech Website to Streamline Pharmaceutical Industry Solutions
KRTL Biotech
Jan 8
Unlocking Opportunities: Why Foreign Pharmaceutical Companies Should Register with the FDA
KRTL Biotech
Dec 29, 2024
KRTL Holding Appoints David Orn to Board of Directors
KRTL Biotech
Dec 19, 2024
KRTL Holding Announces KRTL Biotech Facilitates FDA Registration of SIGMACORP as a U.S. Pharmaceutical Manufacturer
KRTL Biotech
Dec 5, 2024
A Milestone for KRTL Holding Group, Inc. (OTC: KRTL)
KRTL Biotech
Nov 26, 2024
Begin Your Journey
bottom of page
